Scagliotti GV, et al. Nintedanib + pemetrexed/cisplatin in patients with unresectable MPM: phase III results from the LUME-Meso trial. IASLC 2018, abstract PL02.09.
Triplet inductiechemotherapie bij hoogrisico lokaal gevorderd rectumcarcinoom
feb 2024 | Chirurgie, Maag-darm-leveroncologie, Radiotherapie